Zepbound 5 mg

Zepbound 5 mg (Tirzepatide)

Zepbound 5 mg contains tirzepatide, a prescription medicine that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It is designed for once-weekly subcutaneous administration and is used under the supervision of a qualified healthcare professional.

Tirzepatide works through complementary hormonal pathways involved in appetite regulation, food intake, and glucose metabolism. By activating GIP and GLP-1 receptors, it can help support reduced appetite and caloric intake while also improving blood-sugar regulation.

Key Information

• Active Ingredient: Tirzepatide
• Strength: 5 mg
• Dosage Form: Injection
• Administration: Subcutaneous
• Frequency: Once weekly, as prescribed
• Therapeutic Class: GIP/GLP-1 receptor agonist
• Prescription Status: Prescription medication